RPL17 and glioma: Qian et al. found that the level of IFN-γ in mouse gliomas is positively correlated with the PD-L1 expression, and scores based on IFN-γ-induced genes can serve as supplementary prognostic indicators for anti-PD-1/PD-L1 therapy [29].